Clinical trials
Cerebral Palsy trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
176 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 20 |
| 2022 | 19 |
| 2023 | 39 |
| 2024 | 40 |
| 2025 | 18 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 115 |
| Recruiting | 25 |
| Unknown status | 21 |
| Active, not recruiting | 8 |
| Not yet recruiting | 6 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Riphah International University | 116 |
| University of Lahore | 15 |
| Ibadat International University, Islamabad | 7 |
| Superior University | 6 |
| Foundation University Islamabad | 4 |
| Lahore University of Biological and Applied Sciences | 4 |
| Ziauddin University | 3 |
| Dow University of Health Sciences | 2 |
| Health Education Research Foundation (HERF) | 2 |
| Isra University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebral Palsy | 176 |
| Muscle Spasticity | 18 |
| Hemiplegia | 4 |
| Constipation | 3 |
| Gait Disorders, Neurologic | 3 |
| Communication Disorders | 1 |
| Down Syndrome | 1 |
| Dysarthria | 1 |
| Epilepsy | 1 |
| Feeding and Eating Disorders | 1 |
Trials
Showing 1 to 25 of 176. Each trial links to its page on Pharma Observatory.
76 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.